Invention Grant
- Patent Title: Cationic peptides for activating Lck
-
Application No.: US17055250Application Date: 2019-05-15
-
Publication No.: US12134663B2Publication Date: 2024-11-05
- Inventor: Michael Valentine Agrez
- Applicant: Interk Peptide Therapeutics Limited
- Applicant Address: AU New South Wales
- Assignee: Interk Peptide Therapeutics Limited
- Current Assignee: Interk Peptide Therapeutics Limited
- Current Assignee Address: AU New South Wales
- Priority: AU2018901672 20180515
- International Application: PCT/AU2019/050462 WO 20190515
- International Announcement: WO2019/218015 WO 20191121
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61K38/00 ; A61P35/00 ; A61P35/04 ; C07K7/06
Abstract:
The present invention related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.
Public/Granted literature
- US20210380639A1 Activating Agents Public/Granted day:2021-12-09
Information query
